Français
English
Antibody Product Overview
| ELK.No | ES2356 |
| Product name | Fnk rabbit pAb |
| Reactivity | Human;Mouse;Rat |
| Applications | WB;ELISA |
| Other name | PLK3; CNK; FNK; PRK; Serine/threonine-protein kinase PLK3; Cytokine-inducible serine/threonine-protein kinase; FGF-inducible kinase; Polo-like kinase 3; PLK-3; Proliferation-related kinase |
| Size | 100μL |
| Unit price ($) | 248 |
| Human gene ID | 1263 |
| Human Swiss-Prot | Q9H4B4 |
| Source | Rabbit |
| Isotype | IgG |
| Target | Fnk |
| Fields | >>FoxO signaling pathway;>>C-type lectin receptor signaling pathway;>>Tuberculosis |
| Gene name | PLK3 |
| Protein name | Serine/threonine-protein kinase PLK3 |
| Human gene link | View Human Gene |
| Human Swiss link | View Human Swiss-Prot |
| Mouse gene ID | |
| Mouse gene link | |
| Mouse Swiss-Prot | Q60806 |
| Mouse Swiss link | View Mouse Swiss-Prot |
| Rat gene ID | 58936 |
| Rat gene link | View Rat Gene |
| Rat Swiss-Prot | Q9R011 |
| Rat Swiss link | View Rat Swiss-Prot |
| Immunogen | The antiserum was produced against synthesized peptide derived from human PLK3. AA range:231-280 |
| Specificity | Fnk Polyclonal Antibody detects endogenous levels of Fnk protein. |
| Formulation | Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. |
| Clonality | Polyclonal |
| Dilution | Western Blot: 1/500 - 1/2000. ELISA: 1/10000. Not yet tested in other applications. |
| Purification | The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Concentration | 1 mg/ml |
| Storage stability | -20°C/1 year |
| Molecular Weight (Da) | |
| Observed band (KD) | 70kD |
| Background | The protein encoded by this gene is a member of the highly conserved polo-like kinase family of serine/threonine kinases. Members of this family are characterized by an amino-terminal kinase domain and a carboxy-terminal bipartite polo box domain that functions as a substrate-binding motif and a cellular localization signal. Polo-like kinases are important regulators of cell cycle progression. This gene has also been implicated in stress responses and double-strand break repair. In human cell lines, this protein is reported to associate with centrosomes in a microtubule-dependent manner, and during mitosis, the protein becomes localized to the mitotic apparatus. Expression of a kinase-defective mutant results in abnormal cell morphology caused by changes in microtubule dynamics and mitotic arrest followed by apoptosis. [provided by RefSeq, Sep 2015], |
| Function | catalytic activity:ATP + a protein = ADP + a phosphoprotein.,function:Serine/threonine protein kinase involved in regulating M phase functions during the cell cycle. May also be part of the signaling network controlling cellular adhesion. In vitro, is able to phosphorylate CDC25C and casein.,induction:Cytokine and cellular adhesion trigger FNK induction.,PTM:Phosphorylated as cells enter mitosis and dephosphorylated as cells exit mitosis.,similarity:Belongs to the protein kinase superfamily.,similarity:Belongs to the protein kinase superfamily. Ser/Thr protein kinase family. CDC5/Polo subfamily.,similarity:Contains 1 protein kinase domain.,similarity:Contains 2 POLO box domains.,subunit:Binds to the calcium/integrin-binding protein (CIB). This interaction probably occurs via the POLO-box domain.,tissue specificity:Transcripts are highly detected in placenta, lung, followed by skeletal mu |
| Subcellular location | Cytoplasm. Nucleus. Nucleus, nucleolus. Golgi apparatus. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Translocates to the nucleus upon cisplatin treatment. Localizes to the Golgi apparatus during interphase. According to a report, PLK3 localizes only in the nucleolus and not in the centrosome, or in any other location in the cytoplasm (PubMed:17264206). The discrepancies in results may be explained by the PLK3 antibody specificity, by cell line-specific expression or post-translational modifications. . |
| Expression | Transcripts are highly detected in placenta, lung, followed by skeletal muscle, heart, pancreas, ovaries and kidney and weakly detected in liver and brain. May have a short half-live. In cells of hematopoietic origin, strongly and exclusively detected in terminally differentiated macrophages. Transcript expression appears to be down-regulated in primary lung tumor. |
Additional Images
No image
Western Blot analysis of various cells using Fnk Polyclonal Antibody
No image
Western blot analysis of lysates from HepG2 cells, using PLK3 Antibody. The lane on the right is blocked with the synthesized peptide.
No image
Western blot analysis of the lysates from RAW264.7cells using PLK3 antibody.
No image
: AO-06-ES2356-100
: 10 Items
Hurry! only 10 items left in stock.
Use collapsible tabs for more detailed information that will help customers make a purchasing decision.
Ex: Shipping and return policies, size guides, and other common questions.
- Paste the label on a flat surface on the package
- Make sure that both 1D and 2D barcodes are clearly visible
- Ensure that the label is smooth and isn’t creased or wrinkled
- Check for any tears, dents, holes or scratches
- Pack your product tightly, with the right size packaging
- Ensure both barcodes are on a flat surface of the package